{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-08-27",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 6
    }
  },
  "results": [
    {
      "discontinued_date": "10/20/2025",
      "update_type": "New",
      "initial_posting_date": "10/20/2025",
      "package_ndc": "0781-3315-70",
      "generic_name": "Oxaliplatin Injection",
      "contact_info": "800-525-8747",
      "related_info": "Discontinuation of the manufacture of the drug",
      "openfda": {
        "application_number": [
          "ANDA078817"
        ],
        "brand_name": [
          "OXALIPLATIN"
        ],
        "generic_name": [
          "OXALIPLATIN"
        ],
        "manufacturer_name": [
          "Sandoz Inc"
        ],
        "product_ndc": [
          "0781-3315",
          "0781-3317"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAVENOUS"
        ],
        "substance_name": [
          "OXALIPLATIN"
        ],
        "rxcui": [
          "1736776",
          "1736781"
        ],
        "spl_id": [
          "f3766495-fce3-461c-8c95-e890f5e3383f"
        ],
        "spl_set_id": [
          "ab162009-6f84-4d56-ab56-5e84409ec814"
        ],
        "package_ndc": [
          "0781-3315-70",
          "0781-3317-80"
        ],
        "nui": [
          "N0000175413",
          "N0000175073"
        ],
        "pharm_class_epc": [
          "Platinum-based Drug [EPC]"
        ],
        "unii": [
          "04ZR38536J"
        ]
      },
      "update_date": "10/20/2025",
      "therapeutic_category": [
        "Oncology"
      ],
      "dosage_form": "Injection",
      "presentation": "Oxaliplatin, Injection, 5 mg/1 mL (NDC 0781-3315-70)",
      "company_name": "Sandoz Inc.",
      "status": "To Be Discontinued"
    }
  ]
}